Therapeutic equivalence [Design Issues]

posted by raghu – India, 2011-02-09 11:07 (5117 d 14:06 ago) – Posting: # 6600
Views: 6,053

Dear Mr Kishore,

You can conduct BE study in healthy volunteers if the anticancer drug not shows any cytotoxic or any major health risk for participating healthy subjects.

Therapeutic equivalence study should be conducted in patients.

Regards
Raghu.

Complete thread:

UA Flag
Activity
 Admin contact
23,380 posts in 4,914 threads, 1,661 registered users;
35 visitors (0 registered, 35 guests [including 3 identified bots]).
Forum time: 01:14 CET (Europe/Vienna)

Everything is trivial, if you know the answer.    Thomas Jaki

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5